110269 ⎘
Reverse transcribing RNA viruses; Details; Retroviridae Virus like particles [VLP]
Transduction of gammadelta T cells with pseudotyped retroviral vectors
#2NUCLEIC ACIDS ENCODING HUMAN ENDOGENOUS RETROVIRUS K (HERV-K) ENVELOPE PROTEINS CONTAINING MODIFIED IMMUNOSUPPRESSIVE DOMAINS (ISD) AND USES THEREOF
#3METHODS AND PRODUCTS FOR GENETIC ENGINEERING
#4CHARACTERIZATION AND INACTIVATION OF ENDOGENOUS RETROVIRUSES IN CHINESE HAMSTER OVARY CELLS
#5VACCINE FOR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF A DISEASE
#6METHODS AND PRODUCTS FOR GENETIC ENGINEERING
#7METHODS AND PRODUCTS FOR GENETIC ENGINEERING
#8LTR TRANSPOSON COMPOSITIONS AND METHODS
#9Minimal Human-Derived Virus-Like Particles and Methods of Use Thereof for Delivery of Biomolecules
#10Vaccine for use in the prophylaxis and/or treatment of a disease
#11Methods and products for genetic engineering
#12VLP-based bivalent Ebola vaccines and methods of making and using same
#13Methods and products for genetic engineering
#14METHODS AND KITS FOR QUANTIFYING THE REMOVAL OF MOCK VIRUS PARTICLES FROM A PURIFIED SOLUTION
#15ENGINEERED HUMAN-ENDOGENOUS VIRUS-LIKE PARTICLES AND METHODS OF USE THEREOF FOR DELIVERY TO CELLS
#16ENGINEERED HUMAN-ENDOGENOUS VIRUS-LIKE PARTICLES AND METHODS OF USE THEREOF FOR DELIVERY TO CELLS
#17ENGINEERED HUMAN-ENDOGENOUS VIRUS-LIKE PARTICLES AND METHODS OF USE THEREOF FOR DELIVERY TO CELLS
#18A VACCINE FOR USE IN THE PROPHYLAXIS AND/OR TREATMENT OF A DISEASE
#19COMPOSITIONS AND METHODS FOR DELIVERING CARGO TO A TARGET CELL
#20Vaccine for use in the prophylaxis and/or treatment of a disease
#21siRNA EXPRESSION VECTOR
#22Vaccine for use in the prophylaxis and/or treatment of a disease
#23ENGINEERED HUMAN-ENDOGENOUS VIRUS-LIKE PARTICLES AND METHODS OF USE THEREOF FOR DELIVERY TO CELLS
#24VIRUS-LIKE PARTICLE
#25CHARACTERIZATION AND INACTIVATION OF ENDOGENOUS RETROVIRUSES IN CHINESE HAMSTER OVARY CELLS
#26VLP-based bivalent ebola vaccines and methods of making and using same
#27Methods and products for genetic engineering
#28STOCK SOLUTION OF RETROVIRUS LIKE PARTICLES WITH METHOD AND KIT
#29VLP-BASED MONOVALENT EBOLA VACCINES AND METHODS OF MAKING AND USING SAME
#30Methods and kits for quantifying the removal of mock virus particles from a purified solution
#31Methods and products for genetic engineering
#32STOCK SOLUTION OF RETROVIRUS LIKE PARTICLES WITH METHOD AND KIT
#33Detection of particle-contained reverse transcriptase activity
#34Methods for evaluating viral clearance from a process solution employing mock viral particles
#35Antibodies against chikungunya virus and uses thereof
#36Methods for evaluating viral clearance from a biopharmaceutical solution employing mock viral particles